بدائل البحث:
largest decrease » larger decrease (توسيع البحث)
marked decrease » marked increase (توسيع البحث)
026 decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), nn decrease (توسيع البحث)
6 026 » n 026 (توسيع البحث)
largest decrease » larger decrease (توسيع البحث)
marked decrease » marked increase (توسيع البحث)
026 decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), nn decrease (توسيع البحث)
6 026 » n 026 (توسيع البحث)
-
1
-
2
-
3
-
4
-
5
-
6
Data Sheet 1_Empagliflozin’s cardioenergetic protective effects through PPARα pathway modulation in heart failure.pdf
منشور في 2025"…Post-treatment, MRGlu and glucose uptake decreased markedly in the empagliflozin (EMPG) group, while no significant changes were observed in the fenofibrate (FF) group. …"
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Baseline demographic characteristics.
منشور في 2025"…Group 2 exhibited a significantly greater decrease in GCC thickness compared with Group 1(P = 0.026).…"
-
15
-
16
(A-H). Case 1: primary subcutaneous facial alveolar echinococcosis.
منشور في 2025"…<p><b>(A)</b> Left frontal swelling at diagnosis. <b>(B)</b> Marked regression of the lesion after 6 months of albendazole therapy. …"
-
17
-
18
Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups.
منشور في 2025"…<p>In the recurrence group, BCVA (logMAR ± standard deviation) showed no significant change from baselines (0.37 ± 0.20) to 0.35 ± 0.23, 0.35 ± 0.18, 0.31 ± 0.23, 0.34 ± 0.26, 0.28 ± 0.30, and 0.24 ± 0.23 at 1, 3, 6, 12, 24, and 36 months, respectively (Kruskal–Wallis test, P = 0.45). …"
-
19
Annual number of outpatient visits in all eyes.
منشور في 2025"…In the recurrence group, BCVA (logMAR) showed no significant improvement over time: 0.37 ± 0.20 preoperatively and 0.35 ± 0.23, 0.35 ± 0.18, 0.31 ± 0.23, 0.34 ± 0.26, 0.28 ± 0.30, and 0.24 ± 0.23 at 1, 3, 6, 12, 24, and 36 months, respectively (Kruskal-Wallis test, p = 0.45). …"
-
20